Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.
about
Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognitionThe current conceptualization of negative symptoms in schizophreniaThe functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question.The evolution of drug development in schizophrenia: past issues and future opportunities.How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-upThe brief negative symptom scale: psychometric properties.Characterization of the cognitive impairments induced by prenatal exposure to stress in the rat.Does sex influence the relation between symptoms and neurocognitive functions in schizophrenia?Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.Symptom dimensions and outcome in schizophreniaTreating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocolLack of association between COMT gene and deficit/nondeficit schizophrenia.Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.The NIMH-MATRICS consensus statement on negative symptoms.Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.Persistent negative symptoms in schizophrenia: an overview.Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosisFamiliality of Psychotic Disorders: A Polynosologic Study in Multiplex Families.Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.Future in psychopathology research.Progress in the study of negative symptoms.William T. Carpenter Jr: 35 years of clinical trials.HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework.Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitorRDoC and DSM-5: what's the fuss?Current psychopathological issues in psychosis: towards a phenome-wide scanning approach.Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: A Meta-analysis.Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.Disentangling Disease Heterogeneity with Max-Margin Multiple Hyperplane ClassifierPatterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire
P2860
Q24792471-2B87EA7E-A94E-45FC-A01C-8E617C74E904Q30364829-996FF8AA-78CB-49F2-B713-CB32D5C881E0Q30477381-1F7CF1DD-A3FF-417E-98A1-9086D1AA9C01Q30487850-790EFC42-5B8E-4514-8569-E8E0F1F60CB6Q33566091-B70AC177-AC7B-4EED-AD5C-195288BBBADCQ33608454-94D1924E-6A4B-4E48-BD45-7D31D159122CQ34374222-6C24EB9E-2961-4885-B6AE-21DF626FBF89Q34464866-A0B7D2BC-0598-4D73-B040-898BD2D2AB97Q34701102-0F47B138-FA4D-47A1-91EE-5AA75D55A5D3Q34884773-8731255A-71CE-4E64-A00A-9874825A5B57Q34966395-04FC0F84-0320-4415-B323-8A4EB0E1DB26Q35107748-E6CDDB60-D625-4351-9B50-377C093BCF78Q35250772-0EE477C6-73F3-4FF5-A1C0-BB9CD9558852Q35738997-F687153A-D73F-4CA0-8C8C-95839C14AEC3Q36397900-571D4A8A-44E7-47A3-8709-62E2F4ED2D7EQ36412864-826DB9FC-F1D1-4F95-AC61-4EA1BA7D82F9Q36651056-71CB2EDD-5B12-403B-A926-3C68B5A5EB5CQ36840475-092B6D57-835D-49C7-A21A-6B9DF1DD7312Q36994844-63A6BEC1-651F-496F-92C9-DCF3F6846276Q37189980-C24399A7-7290-4248-8266-E63D6BE41EB5Q37602607-6E908CB8-DC1E-4F54-BC59-C0ACB4BC0731Q37602615-92A5D1E0-DD0E-48FB-8D32-4D77E74FEC04Q37602624-DFCDE26B-EE41-4CDD-B469-1C5BEF81AB71Q39962501-D9F094CC-2FE8-438F-A632-F888A51FDD21Q41957493-6A7F388C-88D1-4F7F-8C67-47DDA6CA86C8Q42576194-671DBB5C-11CD-4646-875B-BF464EB58913Q43192086-DAC92E9B-56D6-4B9C-A8A8-47A3814D7D8EQ47101583-07D971C0-C0ED-4FF2-84D9-53D586BF101BQ47916430-2674B1A4-19B6-4553-8652-8AA103C3F5B4Q53175063-171A327F-2F5D-4EA6-94DA-DB1F76134C03Q58099454-D6AF7DC5-81C1-4F3A-8BBA-FDA61977674E
P2860
Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@ast
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@en
type
label
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@ast
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@en
prefLabel
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@ast
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@en
P1476
Domains of psychopathology: an ...... eterogeneity in schizophrenia.
@en
P2093
Buchanan RW
Carpenter WT
P304
P407
P577
1994-04-01T00:00:00Z